Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®

Go back to Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
Pfizer Inc. (NYSE: PFE) Delayed: 30.57 +0.62 (2.07%)
Previous Close $29.95    52 Week High $37.39 
Open $30.51    52 Week Low $28.25 
Day High $30.65    P/E 18.53 
Day Low $30.14    EPS $1.65 
Volume 15,948,639